A case of early onset parkinsonism caused by PLA2G6 gene mutation
Objective: To report and follow up a case of early-onset parkinsonism (EOP) caused by mutation of PLA2G6 gene and to improve the understanding and treatment…PPMI driven sample size estimation for clinical trials in Parkinson’s disease
Objective: To utilize clinical, imaging and CSF data from the Parkinson’s Progression Markers Initiative (PPMI) to estimate the sample size for disease modification studies in…Improvement in Patient Perceived Quality of Life with DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia
Objective: We describe the quality of life outcome from an open-label trial of daxibotulinumtoxinA for injection (Daxi) in cervical dystonia (CD) as measured by the…The Research of the Structural Changes of Cerebellar Tissue in Tremor-type Parkinson’s Disease Based on DKI
Objective: Using Diffusion Kurtosis Imaging (DKI) to observe the structural changes of the cerebellum in patients with tremor-type Parkinson’s Disease (PD), and to provide a…Design and Status of the BIIB054 SPARK Trial
Objective: To describe the design and status of the BIIB054 SPARK trial of the safety and potential efficacy of a monoclonal antibody (mAb) targeting alpha-synuclein…Comparison of virtual-reality-gaming and activity-based gait and balance training on gait, balance and quality of life in patients with Parkinson’s disease
Objective: Investigate and compare the effects of virtual-reality-gaming(VRG) and activity-based gait and balance training (AGBT) on gait and balance parameters (cadence(CD), stride length (SDL), step…Intraoperative local field potential recordings from deep brain stimulation electrodes help predict efficacy of subthalamic nucleus stimulation in patients with Parkinson’s disease
Objective: Subthalamic nucleus (STN) deep brain stimulation(DBS) is an effective treatment for advanced Parkinson's disease (PD). Two electrophysiological techniques aid identification of the optimal target.…Development of evidence-based clinical practice guideline (CPG) of complementary and alternative medicine (CAM) for Parkinson’s disease (PD)
Objective: The purpose of this CPG was to describe the state of evidence on CAM interventions for PD reflecting current clinical practice. Background: Many patients…Open-label extension (OLE) of a multiple ascending dose (MAD) study of BIIB092 in participants with PSP: Safety analysis
Objective: To assess safety of BIIB092 in participants with progressive supranuclear palsy (PSP) in an OLE of a MAD study. Background: BIIB092 is a humanized…Levodopa effect on non-motor symptoms in late stage Parkinson’s disease
Objective: To assess responsiveness of non-motor symptoms (NMS) to Levodopa (L-dopa) and to describe the NMS burden in late stage Parkinson's disease (PD). Moreover, to…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.